Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity February ...

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence to accelerate oncology drug discovery and development, today announced that CEO and ...

A UCT Summer School excursion unpacked the fascinating journey from molecule to medicine, blending storytelling, science and ...

AI has been hailed as a way to speed up historically sluggish drug development, but an entirely AI-designed drug has yet to be approved by the FDA. The furthest along is likely Insilico Medicine’s ...

Strategic Priorities and the Future of Life Sciences' Featuring Serina Therapeutics’ CEO - Wednesday, February ...

Corbus Pharmaceuticals maintains a 'Hold' rating as it advances CRB-701 for HNSCC and CRB-913 for obesity. Click here to read ...

Data support potential of isaralgagene civaparvovec as a one-time, well tolerated and durable Fabry disease gene therapy to provide meaningful, ...

Human challenge trials offer a complementary approach. By safely and deliberately exposing healthy adult volunteers to a well characterised virus under controlled conditions, researchers can generate ...

On Friday, Eli Lilly unveiled its plans for a $3.5 billion pharmaceutical plant to be built on Main Street in Upper Macungie Township. It’s one of four multi-billion-dollar facilities announced by ...

Rognlin’s, Inc., which owns 450 acres within the city limits, held a workshop on Jan. 21to discuss the vision of the property ...

The shelter, just south of Grant Line Road, is expected to open in two years, according to Bontrager; the lease on the city’s ...

Cash Position -- $131.7 million in cash and cash equivalents as of December 31, 2025, with no debt reported. Operating ...